Matches 1 - 50 out of 213 1 2 3 4 5 >


Match Document Document Title
9023790 Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin  
The present invention relates to aqueous solutions useful as pharmaceutical compositions of posaconazole for intravenous administration. These compositions include a solubilizing agent, such as a...
9017956 Use of the genes in the Hog, Ras and cAMP pathway for treatment of fungal infection  
Provided herein are uses of genes for HOG, Ras and cAMP signal transduction pathways to treat fungal infection. To regulate the HOG pathway of Cryptococcus neoformans, roles of SSK1, TCO2, SSK2,...
9018178 Method for the treatment of food, feed and agricultural products with a polyene antifungal compound  
The present invention provides an aqueous antifungal composition comprising a polyene antifungal compound and a thickening agent. The composition can be used in the protection against the...
8993603 Pharmaceutical composition and method using antifungal agent in combination  
A pharmaceutical composition containing one or more antifungal agents selected from an arylamidine derivative represented by the general formula: (wherein R1 represents an amidino group that may...
8980303 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis  
The invention relates to medicine and pharmacology, more particularly to a pharmaceutical composition in the form of vaginal suppositories for treating candidal vaginitis and vulvovaginitis,...
8945061 Otic formulations, methods and devices  
The present invention relates to a formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an...
8946121 Antifungal compositions  
The present invention relates to new antifungal compositions and their use in the treatment of agricultural products.
8937062 Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria  
Compositions comprise a fluoroquinolone having Formulae I-VIII for treating, reducing, ameliorating, or preventing infections caused by some bacteria that are resistant to an antibacterial drug....
8895055 Telodendrimer nanodiscs without apolipoprotein  
The present invention provides a nanodisc without a membrane scaffold protein. The nanodisc includes a telodendrimer and a lipid; the nanodisc does not include a membrane scaffold protein. The...
8883748 Formulation for treating fungal infection  
A novel formulation for treating fungal infections comprising Cholesterol containing Nanosomal Amphotericin B in a Saline Suspension.
8691777 Combination therapy  
The disclosure relates to methods of treating tuberous sclerosis in a subject, comprising administering a composition comprising an mTOR inhibitor and a tyrosine kinase inhibitor to a subject that...
8673866 Stabilized formulation for oral administration of therapeutic agents and related methods  
Stable formulations for the oral administration of therapeutic agents, methods for administering therapeutic agents using the formulations, and methods for treating conditions and diseases using...
8664186 Stambomycin and derivatives, their production and their uses as drugs  
The present invention relates to Stambomycin compounds, their derivatives and their pharmaceutically acceptable salt thereof.
8648050 Methods and formulations for reducing amphotericin B treatment side effects  
A method of ameliorating amphotericin treatment side effects in a mammal that comprises administering a therapeutically effective amount of a formulation that comprises a polyene active ingredient...
8598130 Insecticidal combinations  
A method of controlling or preventing damage to a plant, which comprises applying on the plant or a surrounding area thereof a combination comprising (I) abamectin, and (II) cyflumetofen, in any...
8592382 Formulations for the oral administration of therapeutic agents and related methods  
The present application relates to an oral formulation of amphotericin B and other therapeutic agents, which formulation comprises one or more fatty acid glycerol esters and one or more PEG...
8536144 Anti-fungal composition  
The present invention relates to an improved anti-fungal composition, to a process for preparing it and to its use as a preservative.
8524635 Antifungal composition  
The present invention relates to a process for the treatment of an agricultural product which comprises the addition of a composition which comprises phosphite and natamycin to the agricultural...
8513204 Compositions comprising amphotericin B, mehods and systems  
The present invention comprises compositions and formulations comprising amphotericin B, compositions and formulations comprising amphotericin B with one or more excipients, methods of making...
8470371 Polymeric micellar clusters and their uses in formulating drugs  
Polymeric micellar clusters formed from amphiphilic carbohydrate polymers and their uses in formulating drugs is disclosed, and in particular the finding that amphiphilic carbohydrate polymers are...
8435582 Beverage preservative system containing Pimaricin-Povidone complex  
The present invention provides a beverage preservative system comprising a Pimaricin-providone complex for use in beverages products. The present invention is further directed to beverage products...
8420609 Stable needle-shaped crystals of natamycin  
The present invention describes natamycin comprising needle shaped crystals.
8415312 Compound which is a nystatin derivative  
The present invention relates to compounds which are nystatin derivatives and are anti-fungal agents.
8217013 Polyene diester antibiotics  
The present invention discloses a new polyene diester and its preparation. This polyene diester has a structure of Formula 1, which is used as prodrugs by introducing diester group to polyene...
8187844 Anti-fungal composition  
Natamycin is separated and recovered from a fermentation broth containing biomass and natamycin by adjusting the pH of a natamycin-containing suspension first to dissolve the natamycin in a...
8076373 Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite  
The present invention provides a method for treating wounds and diseases in mammals, caused by mammalian cells involved in an inflammatory response, by altering indigenous in vivo levels of...
7964205 Insecticide and molluscicide composition and methods  
Bait compositions of spinosyns in combination with metal complexones and other mollusicides are provided in an environmentally safe composition that is effective to a treat and/or control a wide...
7910560 Method for increasing breast meat yield in poultry  
A method for increasing breast meat yield in avians by treating the poultry with an effective amount of natamycin. The effective amount of natamycin can be added to the avian's feed wither...
7879809 Fish production  
This invention is directed to the use of spinosyn or a physiologically acceptable derivative or salt thereof for improved production of fish; controlling ectoparasite infestations in aquaculture...
7875282 Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury  
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to...
7867981 Compositions comprising highly purified amphotericin B  
A method for treating fungal infections in a mammal that includes administering a therapeutically effective amount of a composition comprising substantially pure amphotericin B and a...
7816332 Stable aqueous solution of natamycin fungicide  
The present invention provides an aqueous composition comprising—water; —a water miscible solvent; —and a polyene fungicide which is dissolved in the water and water miscible solvent. The present...
7776831 Use of antifungal compositions to treat upper gastrointestinal conditions  
The present invention provides a novel method for treating oral conditions and upper gastrointestinal conditions in a subject by providing an inventive oral dosage form of a pharmaceutical...
7727966 Stable needle-shaped crystals of natamycin  
The present invention describes natamycin comprising needle shaped crystals.
7612045 Compounds, compositions and methods for controlling biofilms and bacterial infections  
The present invention provides compounds and compositions useful for controlling bacterial biofilms as well as for controlling and/or preventing bacterial infections. The compounds of the...
7393837 Inhibition of PEX in the treatment of metabolic bone diseases  
The present invention relates to a method of treating metabolic bone diseases in a patient, which comprises the modulation of PEX activity to modulate the bone micro-environmental concentrations...
7326691 Compositions comprising amphotericin B, methods, and systems  
A composition includes particles including at least about 95 wt % of amphotericin B, wherein the particles have a mass median diameter ranging from about 1.1 μm to about 1.9 μm. Another...
7241741 Methods and compositions for the treatment of asthma and related disorders  
The present invention provides methods for the treatment of respiratory tract mucositis in individuals in need of such treatment, the method comprising the systemic administration to the...
7220726 Antifungal pimaricin compositions and therapeutic methods employing same  
An antifungal composition suitable for parenteral administration to a mammal includes an amount of pimaricin or an antifungal derivative thereof that is effective to inhibit the growth of a fungal...
7205001 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds  
The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt,...
7193706 Computer interfaced scanning fluorescence lifetime microscope applied to directed evolution  
This invention provides a method for screening large numbers of individual cells or colonies of cells using scanning microscopy coupled with fluorescence lifetime measurement and analysis, using...
7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds  
The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt,...
7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds  
The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt,...
7153838 Pharmacologically acceptable solvent vehicles  
An antifungal composition suitable for parenteral administration to a mammal includes an amount of pimaricin or an antifungal derivative thereof that is effective to inhibit the growth of a fungal...
7115576 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate  
The invention relates to novel pharmaceutical forms for antibiotics containing amino sugar, amphotericin B, daunorubicin and doxorubicin, in which the known side effects are reduced and which can...
7094431 Method of healing skin wounds in mammals and a composition therefor  
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or...
7053061 Amphotercin B structured emulsion  
Parenteral compositions of oil-coated-Amphotericin B in structured-emulsion form, having LD50 of at least 400 mg/kg in mice and process for making the same have been described. The process...
7045507 Substituted tetracycline compounds as synergistic antifungal agents  
Methods and compositions for treating for the synergistic treatment of fungal associated disorders are discussed.
7011826 Control of acidosis  
The present invention relates to a vaccine for the prevention of lactic acidosis in a vertebrate, said vaccine comprising at least one isolated microorganism, or fragment or fragments thereof,...
RE38984 Antifungal combination therapy  
There is described antifungal combination therapy comprising the use of known antifungal agents such as the azoles or polyenes in combination with a pneumocandin derivative antifungal agent. More...

Matches 1 - 50 out of 213 1 2 3 4 5 >